 Taylor Triolo
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 20 | 2026 | 3922 | 2.290 |
Why?
| | C-Peptide | 5 | 2026 | 190 | 1.910 |
Why?
| | Islets of Langerhans Transplantation | 2 | 2024 | 70 | 1.430 |
Why?
| | Insulin-Secreting Cells | 7 | 2026 | 392 | 1.280 |
Why?
| | Pluripotent Stem Cells | 3 | 2026 | 82 | 0.910 |
Why?
| | Genetic Predisposition to Disease | 6 | 2026 | 2378 | 0.880 |
Why?
| | Autoantibodies | 12 | 2026 | 1509 | 0.840 |
Why?
| | Insulin | 8 | 2026 | 2512 | 0.820 |
Why?
| | Pancreatitis, Chronic | 1 | 2024 | 64 | 0.800 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2026 | 2158 | 0.780 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 300 | 0.770 |
Why?
| | Hypoglycemic Agents | 5 | 2026 | 1399 | 0.710 |
Why?
| | Blood Glucose | 7 | 2026 | 2341 | 0.700 |
Why?
| | Pancreatectomy | 1 | 2024 | 289 | 0.670 |
Why?
| | Twins, Dizygotic | 1 | 2018 | 108 | 0.540 |
Why?
| | Twins, Monozygotic | 1 | 2018 | 133 | 0.530 |
Why?
| | Diabetes Mellitus | 2 | 2021 | 1097 | 0.520 |
Why?
| | Glucose Tolerance Test | 4 | 2026 | 360 | 0.510 |
Why?
| | Stem Cells | 1 | 2021 | 628 | 0.480 |
Why?
| | Addison Disease | 3 | 2011 | 38 | 0.460 |
Why?
| | Autoimmunity | 3 | 2023 | 933 | 0.440 |
Why?
| | Islets of Langerhans | 2 | 2018 | 846 | 0.400 |
Why?
| | Steroid 21-Hydroxylase | 2 | 2011 | 27 | 0.390 |
Why?
| | Child | 15 | 2026 | 22707 | 0.380 |
Why?
| | Adolescent | 14 | 2026 | 22530 | 0.380 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2026 | 2588 | 0.370 |
Why?
| | Quality of Life | 1 | 2024 | 3204 | 0.350 |
Why?
| | Cell Differentiation | 3 | 2026 | 2046 | 0.340 |
Why?
| | Pancreas | 3 | 2024 | 341 | 0.320 |
Why?
| | Embryonic Stem Cells | 2 | 2021 | 124 | 0.320 |
Why?
| | Glutamate Decarboxylase | 2 | 2022 | 165 | 0.310 |
Why?
| | Disease Progression | 5 | 2026 | 2864 | 0.300 |
Why?
| | Young Adult | 8 | 2026 | 14219 | 0.300 |
Why?
| | Adult | 14 | 2026 | 40777 | 0.270 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2009 | 202 | 0.270 |
Why?
| | Child, Preschool | 7 | 2026 | 11853 | 0.270 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 468 | 0.260 |
Why?
| | Male | 17 | 2026 | 72843 | 0.260 |
Why?
| | Humans | 29 | 2026 | 145475 | 0.260 |
Why?
| | HLA-DR3 Antigen | 2 | 2022 | 76 | 0.260 |
Why?
| | Polymorphism, Genetic | 1 | 2009 | 614 | 0.250 |
Why?
| | Female | 17 | 2026 | 78845 | 0.250 |
Why?
| | Risk Factors | 8 | 2026 | 10885 | 0.250 |
Why?
| | Haplotypes | 4 | 2026 | 499 | 0.240 |
Why?
| | Mass Screening | 3 | 2025 | 1360 | 0.240 |
Why?
| | Administration, Oral | 2 | 2026 | 866 | 0.220 |
Why?
| | HLA Antigens | 2 | 2026 | 240 | 0.210 |
Why?
| | Family | 2 | 2025 | 682 | 0.210 |
Why?
| | Genetic Association Studies | 1 | 2025 | 369 | 0.190 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2022 | 13 | 0.190 |
Why?
| | Prediabetic State | 1 | 2026 | 249 | 0.190 |
Why?
| | Insulins | 1 | 2023 | 38 | 0.180 |
Why?
| | HLA-DR4 Antigen | 1 | 2022 | 74 | 0.180 |
Why?
| | Diabetic Ketoacidosis | 1 | 2024 | 209 | 0.180 |
Why?
| | Insulin Antibodies | 1 | 2022 | 103 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2021 | 273 | 0.170 |
Why?
| | Genotype | 5 | 2026 | 1852 | 0.160 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 159 | 0.160 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 9 | 0.160 |
Why?
| | Risk | 2 | 2021 | 919 | 0.150 |
Why?
| | Transplantation, Homologous | 1 | 2021 | 418 | 0.150 |
Why?
| | Immune System | 1 | 2021 | 180 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2026 | 992 | 0.150 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 100 | 0.140 |
Why?
| | Seroepidemiologic Studies | 1 | 2018 | 171 | 0.130 |
Why?
| | Motor Neurons | 1 | 2020 | 236 | 0.130 |
Why?
| | Diseases in Twins | 1 | 2018 | 116 | 0.130 |
Why?
| | Siblings | 1 | 2018 | 196 | 0.130 |
Why?
| | Twins | 1 | 2018 | 152 | 0.130 |
Why?
| | Hyperglycemia | 1 | 2021 | 379 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2953 | 0.120 |
Why?
| | Environment | 1 | 2018 | 293 | 0.120 |
Why?
| | Retrospective Studies | 2 | 2025 | 17291 | 0.120 |
Why?
| | Hypoglycemia | 1 | 2021 | 479 | 0.120 |
Why?
| | Registries | 1 | 2024 | 2406 | 0.110 |
Why?
| | Oxygen | 1 | 2020 | 978 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1996 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4295 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2026 | 11772 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3904 | 0.090 |
Why?
| | HLA-DQ Antigens | 2 | 2009 | 174 | 0.090 |
Why?
| | HLA-DR Antigens | 2 | 2009 | 220 | 0.090 |
Why?
| | HLA-B Antigens | 1 | 2011 | 58 | 0.080 |
Why?
| | Endocrine Cells | 1 | 2010 | 6 | 0.080 |
Why?
| | Alleles | 2 | 2011 | 894 | 0.080 |
Why?
| | Middle Aged | 3 | 2026 | 36215 | 0.080 |
Why?
| | HLA-DQ beta-Chains | 1 | 2009 | 58 | 0.080 |
Why?
| | Graves Disease | 1 | 2009 | 32 | 0.070 |
Why?
| | Homozygote | 1 | 2009 | 199 | 0.070 |
Why?
| | Nuclear Family | 1 | 2009 | 50 | 0.070 |
Why?
| | HLA-DRB1 Chains | 1 | 2009 | 110 | 0.070 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 157 | 0.070 |
Why?
| | HLA-D Antigens | 1 | 2008 | 30 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2009 | 193 | 0.070 |
Why?
| | Insulin Infusion Systems | 2 | 2023 | 480 | 0.070 |
Why?
| | Reference Values | 1 | 2009 | 798 | 0.060 |
Why?
| | Prospective Studies | 3 | 2026 | 8057 | 0.060 |
Why?
| | Blood Glucose Self-Monitoring | 2 | 2023 | 701 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1041 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5905 | 0.060 |
Why?
| | Slovenia | 1 | 2024 | 3 | 0.050 |
Why?
| | Wales | 1 | 2024 | 25 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2026 | 172 | 0.050 |
Why?
| | New Zealand | 1 | 2024 | 54 | 0.050 |
Why?
| | Italy | 1 | 2024 | 116 | 0.050 |
Why?
| | Germany | 1 | 2024 | 138 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 377 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2013 | 1244 | 0.050 |
Why?
| | Technology | 1 | 2023 | 97 | 0.050 |
Why?
| | Homeodomain Proteins | 1 | 2026 | 523 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1747 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2021 | 219 | 0.040 |
Why?
| | Phantoms, Imaging | 1 | 2021 | 159 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2021 | 155 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 211 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 247 | 0.040 |
Why?
| | Gene Frequency | 2 | 2010 | 487 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 263 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 779 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 502 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3747 | 0.030 |
Why?
| | Calcium | 1 | 2021 | 1190 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1038 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2823 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4554 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3413 | 0.020 |
Why?
| | Mitochondria | 1 | 2020 | 992 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2020 | 4148 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2597 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2803 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2011 | 12 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2010 | 11 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10077 | 0.020 |
Why?
| | Life Style | 1 | 2013 | 485 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2010 | 253 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 407 | 0.020 |
Why?
| | Pedigree | 1 | 2010 | 515 | 0.020 |
Why?
| | Animals | 1 | 2026 | 38030 | 0.010 |
Why?
|
|
Triolo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|